Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

October 27, 2019

Study Completion Date

October 27, 2019

Conditions
Respiratory Depression
Interventions
DRUG

Belbuca 300 µg

Belbuca 300 µg buccal film

DRUG

Belbuca 600 µg

Belbuca 600 µg buccal film

DRUG

Belbuca 900 µg

Belbuca 900 µg buccal film

DRUG

Oxycodone 30 mg

Oxycodone 30 mg capsule

DRUG

Oxycodone 60 mg

Oxycodone 60 mg capsule

DRUG

Placebo

placebo buccal film and oral placebo

Trial Locations (1)

84124

PRA-EDS, Salt Lake City

Sponsors
All Listed Sponsors
collaborator

PRA Health Sciences

INDUSTRY

lead

BioDelivery Sciences International

INDUSTRY